Acumen Pharmaceuticals

ABOS

Börsenwert 122 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Morgan Stanley New York	365.157 $	-19.320 $	-7.821	-5 %
27	27 Susquehanna International Group Bala Cynwyd, Pennsylvania	336.698 $	-1,17 Mio. $	-475.372	-79 %
28	28 Bank of New York Mellon New York	332.086 $	+307.249 $	+124.377	Neu
29	29 Charles Schwab San Francisco, California	307.314 $	+284.329 $	+115.099	Neu
30	30 PFG Investments Woodbury, New York	251.648 $	+33.102 $	+13.400	+17 %
31	31 Catalyst Financial Partners Boston, Massachusetts	239.496 $	–	–	–
32	32 Nuveen Charlotte, North Carolina	169.158 $	+156.506 $	+63.355	Neu
33	33 Millennium Management New York	161.797 $	-1,48 Mio. $	-599.077	-91 %
34	34 Squarepoint New York	139.777 $	+92.231 $	+37.336	+249 %
35	35 Citadel Advisors Miami, Florida	136.301 $	+126.106 $	+51.049	Neu
36	36 Prospera Financial Services Dallas, Texas	133.500 $	–	–	–
37	37 Wells Fargo San Francisco, California	132.661 $	+97.770 $	+39.578	+392 %
38	38 Marshall Wace London, United Kingdom	128.465 $	-357.638 $	-144.775	-75 %
39	39 Deutsche Bank Frankfurt Am Main Ge, Germany	123.172 $	+113.960 $	+46.132	Neu
40	VA 40 Verdad Advisers Boston, Massachusetts	118.756 $	+17.786 $	+7.200	+19 %
41	41 T. Rowe Price Associates Baltimore, Maryland	106.000 $	+97.149 $	+39.327	Neu
42	42 Barclays London, United Kingdom	105.878 $	+22.173 $	+8.976	+29 %
43	43 Qube Research & Technologies (QRT) London, United Kingdom	103.099 $	-202.006 $	-81.774	-68 %
44	44 New York State Common Retirement Fund Albany, New York	96.654 $	+89.425 $	+36.200	Neu
45	45 RhumbLine Advisers Boston, Massachusetts	93.535 $	+86.544 $	+35.034	Neu
46	RC 46 Rangeley Capital New Canaan, Connecticut	93.450 $	–	–	–
47	47 XTX Topco George Town, Cayman Islands	85.798 $	+79.381 $	+32.134	Neu
48	IFPG 48 Intrepid Financial Planning Group Carmel, Indiana	80.501 $	–	–	–
49	49 Y-Intercept (HK) Hong Kong	78.872 $	+72.973 $	+29.540	Neu
50	50 Quantinno Capital Management New York	71.473 $	+66.127 $	+26.769	Neu

Acumen Pharmaceuticals ABOS Börsenwert 122 Mio. $

Acumen Pharmaceuticals

ABOS

Börsenwert 122 Mio. $